Human Longevity Stock

www.humanlongevity.comBioTechFounded: 2013Funding to Date: $49.3MM

Human Longevity is a genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Human Longevity, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Human Longevity investors also invested in these private companies

Team

Management Team

J. Venter
Co-founder and CEO
Yaron Turpaz
Chief Information Officer
Felix Frueh
Chief Scientific Officer
Williams Biggs
Head, Genomic Sequencing

Board Members

Eric Anderson
Intentional Software
David Brenner
University of California, San Diego
James Brewer
University of California, San Diego
Delos Cosgrove
Cleveland Clinic

Other companies like Human Longevity in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$289.42MM

News

The genetic testing company NeoGenomics has acquired Human Longevity’s oncology division, which provides next-generation sequencing services. The division
Dr. Nir Barzilai, a Milken Institute Center for the Future on Aging Longevity Innovator, discusses his latest research and what's ahead.